Newborn and Infant Chronic Lung Disease Program
Despite advances in neonatal care, chronic lung disease (CLD) of infancy — also known as bronchopulmonary dysplasia (BPD) — remains a major source of morbidity and mortality for extremely low birth weight infants. To achieve the best outcome for these infants, care provided by a multidisciplinary team with experience and specialized training is needed.
Housed within the Harriet and Ronald Lassin Newborn/Infant Intensive Care Unit (N/IICU) at Children’s Hospital of Philadelphia (CHOP), the Newborn and Infant Chronic Lung Disease Program offers infants with chronic lung disease — and their families — seamless care from initial evaluation, to treatment and long-term follow-up.
Our goal is to provide lifesaving therapy to all children with CLD — without compromising their long-term quality of life. We offer:
- An experienced team of doctors, nurses and support staff who are experts in the management of infants with chronic lung disease
- A coordinated, multidisciplinary approach to each child’s evaluation and treatment
- Regular communication with families, referring physicians and specialists to create a comprehensive, customized care plan for each child
- The newest and most innovative diagnostic and therapeutic modalities available
- Ongoing research to learn more about CLD causes, explore new treatment options, and enhance outcomes for all children with CLD
Our program also collaborates with other specialists throughout the Hospital as needed to ensure your child receives the comprehensive care they need. Your child will benefit from around-the-clock access to every pediatric subspecialty.
